Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes

References

• Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z. Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B. 2017;7(3):281–291. doi:10.1016/j.apsb.2016.09.001
   PubMed Web of Science ®Google Scholar
• Cholkar K, Dasari SR, Pal D, Mitra AK. Eye: anatomy, physiology and barriers to drug delivery. In: Ocular Transporters and Receptors. Elsevier; 2013:1–36.
   Google Scholar
• El Hoffy NM, Azim EAA, Hathout RM, Fouly MA, Elkheshen SA. Glaucoma: management and future perspectives for nanotechnology-based treatment modalities. Eur J Pharm Sci. 2020;158:105648. doi:10.1016/j.ejps.2020.105648
   PubMed Web of Science ®Google Scholar
• Mandal A, Gote V, Pal D, Ogundele A, Mitra AK. Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa®) for dry eye disease. Pharm Res. 2019;36(2):1–21. doi:10.1007/s11095-018-2556-5
   Web of Science ®Google Scholar
• Prakash P, Gnanaprakasam P, Emmanuel R, Arokiyaraj S, Saravanan M. Green synthesis of silver nanoparticles from leaf extract of Mimusops elengi, Linn. for enhanced antibacterial activity against multi drug resistant clinical isolates. Colloids Surf B Biointerfaces. 2013;108:255–259. doi:10.1016/j.colsurfb.2013.03.017
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Yokoyama M, Opanasopit P, Hayama A, Kawano K, Maitani Y. What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core. J Control Release. 2007;123(1):11–18. doi:10.1016/j.jconrel.2007.07.008
   PubMed Web of Science ®Google Scholar
• Naguib SS, Hathout RM, Mansour S. Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug. Drug Deliv. 2017;24(1):99–108. doi:10.1080/10717544.2016.1233588
   PubMed Web of Science ®Google Scholar
• Hathout RM, Omran MK. Gelatin-based particulate systems in ocular drug delivery. Pharm Dev Technol. 2016;21(3):379–386. doi:10.3109/10837450.2014.999786
   PubMed Web of Science ®Google Scholar
• Wheeler L, WoldeMussie E, Lai R. Role of alpha-2 agonists in neuroprotection. Surv Ophthalmol. 2003;48(2):S47–S51. doi:10.1016/S0039-6257(03)00004-3
   PubMed Web of Science ®Google Scholar
• WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42(12):2849–2855.
   PubMed Web of Science ®Google Scholar
• Adkins JC, Balfour JA. Brimonidine. Drugs Aging. 1998;12(3):225–241. doi:10.2165/00002512-199812030-00005
   PubMed Web of Science ®Google Scholar
• Hathout RM, Gad HA, Abdel-Hafez SM, et al. Gelatinized core liposomes: a new Trojan horse for the development of a novel timolol maleate glaucoma medication. Int J Pharm. 2019;556:192–199. doi:10.1016/j.ijpharm.2018.12.015
   PubMed Web of Science ®Google Scholar
• Abdel-Hafez SM, Hathout RM, Sammour OA. Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs. Int J Biol Macromol. 2014;64:334–340. doi:10.1016/j.ijbiomac.2013.11.041
   PubMed Web of Science ®Google Scholar
• Shokry M, Hathout RM, Mansour S. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: augmented in-vivo efficacy and safe histological profile. Int J Pharm. 2018;545(1–2):229–239. doi:10.1016/j.ijpharm.2018.04.059
   PubMed Web of Science ®Google Scholar
• Pathan I. Transdermal delivery of ethosomes as a novel vesicular carrier for paroxetine hydrochloride: in vitro evaluation and In vivo study. Marmara Pharm J. 2016;20(1):1–6. doi:10.12991/mpj.201620113534
   Google Scholar
• Ramadan AA, Eladawy SA, El-Enin ASMA, Hussein ZM. Development and investigation of timolol maleate niosomal formulations for the treatment of glaucoma. J Pharm Investig. 2020;50(1):59–70. doi:10.1007/s40005-019-00427-1
   Web of Science ®Google Scholar
• Abdel-Hafez SM, Hathout RM, Sammour OA. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy. Colloids Surf B Biointerfaces. 2018;167:63–72. doi:10.1016/j.colsurfb.2018.03.051
   PubMed Web of Science ®Google Scholar
• Nagargoje S, Phatak A, Bhingare C, Chaudhari S. Formulation and evaluation of ophthalmic delivery of fluconazole from ion activated in situ gelling system. Der Pharmacia Lettre. 2012;4(4):1228–1235.
   Google Scholar
• Chen H, Chang X, Weng T, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release. 2004;98(3):427–436. doi:10.1016/j.jconrel.2004.06.001
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of Acetazolamide. Int J Pharm. 2005;306(1–2):71–82. doi:10.1016/j.ijpharm.2005.09.023
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for Acetazolamide: in vitro and in vivo studies. Aaps Pharmscitech. 2007;8(1):E1–E12. doi:10.1208/pt0801001
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm. 2005;290(1–2):155–159. doi:10.1016/j.ijpharm.2004.10.026
   PubMed Web of Science ®Google Scholar
• Efron N, Young G, Brennan NA. Ocular surface temperature. Curr Eye Res. 1989;8(9):901–906.
   PubMed Web of Science ®Google Scholar
• Annapurna M, Sushmitha M, Sevyatha V. Simultaneous determination of brimonidine tartrate and timolol maleate by first derivative and ratio derivative spectroscopy. J Anal Pharm Res. 2017;4(6):00120.
   Google Scholar
• Podczeck F. Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT). Int J Pharm. 1993;97(1–3):93–100. doi:10.1016/0378-5173(93)90129-4
   Web of Science ®Google Scholar
• Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci. 1983;72(10):1189–1191. doi:10.1002/jps.2600721021
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25–35. doi:10.1016/0378-5173(83)90064-9
   Web of Science ®Google Scholar
• Peppas N Analysis of fickian and non-fickian drug release from polymers; 1985.
   Google Scholar
• Peppas N. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110–111.
   PubMedGoogle Scholar
• Sakar F, Özer A, Erdogan S, et al. Nano drug delivery systems and gamma radiation sterilization. Pharm Dev Technol. 2017;22(6):775–784. doi:10.3109/10837450.2016.1163393
   PubMed Web of Science ®Google Scholar
• Kaur IP, Aggarwal D, Singh H, Kakkar S. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1467–1472. doi:10.1007/s00417-010-1383-0
   PubMed Web of Science ®Google Scholar
• Litamoi J, Palya V, Sylla D. Quality control testing of contagious bovine pleuropneumonia live attenuated vaccine: standard operating procedures: food & agriculture org; 1996.
   Google Scholar
• Zolner WJ. Quality-control analytical methods: a guide to quality control testing for the compounding pharmacist. Int J Pharm Compd. 2006;10(4):281.
   PubMedGoogle Scholar
• Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163. doi:10.1038/nprot.2007.521
   PubMed Web of Science ®Google Scholar
• Melena J, Santafé J, Segarra J. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits. J Pharmacol Exp Ther. 1998;284(1):278–282.
   PubMed Web of Science ®Google Scholar
• Shields MB. Textbook of Glaucoma. Williams & Wilkins; 1987.
   Google Scholar
• Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82(3):377–390.
   Google Scholar
• Sharpe R. The Draize test—motivations for change. Food Chem Toxicol. 1985;23(2):139–143. doi:10.1016/0278-6915(85)90005-5
   PubMed Web of Science ®Google Scholar
• Shamim B. Alternatives to the Draize Eye Test. PharmaTutor. 2014;2(10):45–57.
   Google Scholar
• Abozeid SM, Hathout RM, Abou-Aisha K. Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7. Colloids Surf B Biointerfaces. 2016;145:607–616. doi:10.1016/j.colsurfb.2016.05.066
   PubMed Web of Science ®Google Scholar
• Box GE, Cox DR. An analysis of transformations. J R Stat Soc. 1964;26(2):211–243.
   Google Scholar
• Osborne J. Improving your data transformations: applying the Box-Cox transformation. Pract Assess Res Evaluation. 2010;15(1):12.
   Google Scholar
• Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 2014;4(4):1.
   Google Scholar
• Kazi KM, Mandal AS, Biswas N, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374. doi:10.4103/0110-5558.76435
   PubMedGoogle Scholar
• Lelkes PI. Methodological Aspects Dealing with Stability Measurements of Liposomes in vitro Using the Carboxyfluorescein-Assay. Boca Raton, FL: CRC Press; 1984.
   Google Scholar
• Ammar H, Haider M, Ibrahim M, El Hoffy N. In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration. Drug Deliv. 2017;24(1):414–421. doi:10.1080/10717544.2016.1259371
   PubMed Web of Science ®Google Scholar
• hui-hui Z, qiu-hua L, zhi-jun Y, wei-san P, shu-fang N. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo. Drug Deliv. 2011;18(7):502–510. doi:10.3109/10717544.2011.595839
   PubMed Web of Science ®Google Scholar
• El Kayal M, Nasr M, Mortada N, Elkheshen S. Optimization of the colloidal properties of different vesicular systems aiming to encapsulate (-)- epigallocatechin-3-gallate. Farmacia. 2020;68(1):97–110. doi:10.31925/farmacia.2020.1.14
   Web of Science ®Google Scholar
• Arnett EM, Harvey N, Johnson E, Johnston DS, Chapman D. No phospholipid monolayer-sugar interactions. Biochemistry. 1986;25(18):5239–5242. doi:10.1021/bi00366a038
   PubMed Web of Science ®Google Scholar
• Cadenhead D, Bean K. Selected lipid monolayers on aqueous-glycerol and aqueous-urea substrates. Biochimica et Biophysica Acta (BBA)-Biomembranes. 1972;290:43–50. doi:10.1016/0005-2736(72)90050-8
   PubMed Web of Science ®Google Scholar
• Alonso-Romanowski S, Biondi A, Disalvo E. Effect of carbohydrates and glycerol on the stability and surface properties of lyophilized liposomes. J Membr Biol. 1989;108(1):1–11. doi:10.1007/BF01870420
   Web of Science ®Google Scholar
• Arceo E, Marsden P, Bergman RG, Ellman JA, An efficient didehydroxylation method for the biomass-derived polyols glycerol and erythritol. Mechanistic studies of a formic acid-mediated deoxygenation. Chem Comm. 2009;23:3357–3359. doi:10.1039/b907746d
   PubMed Web of Science ®Google Scholar
• Hathout RM, Gad HA, Metwally AA. Gelatinized‐core liposomes: toward a more robust carrier for hydrophilic molecules. J Biomed Mater Res A. 2017;105(11):3086–3092. doi:10.1002/jbm.a.36175
   PubMed Web of Science ®Google Scholar
• Kim NJ, Harris A, Gerber A, et al. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine. Br J Ophthalmol. 2014;98(4):427–431. doi:10.1136/bjophthalmol-2013-304028
   PubMed Web of Science ®Google Scholar
• Gruner SM. Intrinsic curvature hypothesis for biomembrane lipid composition: a role for nonbilayer lipids. Proc Natl Acad Sci. 1985;82(11):3665–3669. doi:10.1073/pnas.82.11.3665
   PubMed Web of Science ®Google Scholar
• Chiou G Topical treatment of ocular hypertension, glaucoma, ischemic retinopathy and age-related macular degeneration with ophthalmic formulation of dopamine antagonists: google patents; 2003.
   Google Scholar
• Ahmed I, Chaudhuri B. Evaluation of buffer systems in ophthalmic product development. Int J Pharm. 1988;44(1–3):97–105. doi:10.1016/0378-5173(88)90105-6
   Web of Science ®Google Scholar
• Zhu H, Chauhan A. Effect of viscosity on tear drainage and ocular residence time. Optom Vis Sci. 2008;85(8):E715–E725. doi:10.1097/OPX.0b013e3181824dc4
   PubMed Web of Science ®Google Scholar
• Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 2009;380(1–2):72–79. doi:10.1016/j.ijpharm.2009.06.040
   PubMed Web of Science ®Google Scholar
• Shen Y, Jin E, Zhang B, et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc. 2010;132(12):4259–4265. doi:10.1021/ja909475m
   PubMed Web of Science ®Google Scholar
• Pattnaik S, Swain K, Mallick S, Lin Z. Effect of casting solvent on crystallinity of ondansetron in transdermal films. Int J Pharm. 2011;406(1–2):106–110. doi:10.1016/j.ijpharm.2011.01.009
   PubMed Web of Science ®Google Scholar
• Coleman NJ, Craig DQ. Modulated temperature differential scanning calorimetry: a novel approach to pharmaceutical thermal analysis. Int J Pharm. 1996;135(1–2):13–29. doi:10.1016/0378-5173(95)04463-9
   Web of Science ®Google Scholar
• De Souza JF, Maia KN, Patrício PSDO, et al. Ocular inserts based on chitosan and brimonidine tartrate: development, characterization and biocompatibility. J Drug Deliv Sci Technol. 2016;32:21–30. doi:10.1016/j.jddst.2016.01.008
   Web of Science ®Google Scholar
• Singh HK, Shinde AU. Development and evaluation of novel polymeric nanoparticles of brimonidine tartrate. Curr Drug Deliv. 2010;7(3):244–251. doi:10.2174/156720110791561008
   PubMedGoogle Scholar
• Chapman D, Collin D. Differential thermal analysis of phospholipids. Nature. 1965;206(4980):189. doi:10.1038/206189a0
   PubMed Web of Science ®Google Scholar
• Demetzos C. Differential scanning calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability. J Liposome Res. 2008;18(3):159–173. doi:10.1080/08982100802310261
   PubMed Web of Science ®Google Scholar
• Mukherjee I, Rosolen M. Thermal transitions of gelatin evaluated using DSC sample pans of various seal integrities. J Therm Anal Calorim. 2013;114(3):1161–1166. doi:10.1007/s10973-013-3166-4
   Web of Science ®Google Scholar
• Kitayama H, Takechi Y, Tamai N, Matsuki H, Yomota C, Saito H. Thermotropic phase behavior of hydrogenated soybean phosphatidylcholine–cholesterol binary liposome membrane. Chem Pharm Bull (Tokyo). 2014;62(1):58–63. doi:10.1248/cpb.c13-00587
   PubMed Web of Science ®Google Scholar
• Maiti S, Paul S, Mondol R, Ray S, Sa B. Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation. Aaps Pharmscitech. 2011;12(2):755–763. doi:10.1208/s12249-011-9643-9
   PubMed Web of Science ®Google Scholar
• Fathalla D, Soliman G, Fouad E. Development and in vitro/in vivo evaluation of liposomal gels for the sustained ocular delivery of latanoprost. J Clin Exp Ophthalmol. 2015;6(390):2.
   Google Scholar
• Sikkandar S, Jayakumar S, Gunasekaran S, Renugadevi T, Alwar B. Study on the analysis of human gallstones using Fourier transform infrared spectroscopic technique. Int J ChemTech Res. 2011;3(1):149–154.
   Google Scholar
• Lai J-Y, Li Y-T. Influence of cross-linker concentration on the functionality of carbodiimide cross-linked gelatin membranes for retinal sheet carriers. J Biomater Sci Polym Ed. 2011;22(1–3):277–295. doi:10.1163/092050609X12603600753204
   PubMed Web of Science ®Google Scholar
• Lai J-Y, Hsieh A-C. A gelatin-g-poly (N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine. Biomaterials. 2012;33(7):2372–2387. doi:10.1016/j.biomaterials.2011.11.085
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42. doi:10.1016/0168-3659(87)90035-6
   Google Scholar
• Campbell M. Lipids and membranes. In: Campbell MK, editor. Biochemistry. New York, NY, USA: Saunders College Publishing; 1995:1423–1430.
   Google Scholar
• Yeh M-K, Tung S-M, Lu D-W, Chen J-L, Chiang C-H. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles. J Microencapsul. 2001;18(4):507–519. doi:10.1080/02652040010018100
   PubMed Web of Science ®Google Scholar
• Maurice D. Kinetics of topically applied ophthalmic drugs. In: Ophthalmic Drug Delivery. Springer; 1987:19–26.
   Google Scholar
• Balasubramaniam J, Kant S, Pandit JK. In vitro and in vivo evaluation of Gelrite® gellan gum-based ocular delivery system for indomethacin. ACTA PHARMACEUTICA-ZAGREB. 2003;53(4):251–262.
   PubMedGoogle Scholar
• Singh J, Chhabra G, Pathak K. Development of Acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study. Drug Dev Ind Pharm. 2014;40(9):1223–1232. doi:10.3109/03639045.2013.814061
   PubMed Web of Science ®Google Scholar
• Friess W. Collagen–biomaterial for drug delivery. Eur J Pharm Biopharm. 1998;45(2):113–136. doi:10.1016/s0939-6411(98)00017-4
   PubMed Web of Science ®Google Scholar
• Yousry C, Fahmy RH, Essam T, El-Laithy HM, Elkheshen SA. Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation. Drug Dev Ind Pharm. 2016;42(11):1752–1762. doi:10.3109/03639045.2016.1171335
   PubMed Web of Science ®Google Scholar
• Yousry C, Elkheshen SA, El-Laithy HM, Essam T, Fahmy RH. Studying the influence of formulation and process variables on vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery. Eur J Pharm Sci. 2017;100:142–154. doi:10.1016/j.ejps.2017.01.013
   PubMed Web of Science ®Google Scholar
• Nagai N, Yoshioka C, Mano Y, et al. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure. Exp Eye Res. 2015;132:115–123. doi:10.1016/j.exer.2015.01.022
   PubMed Web of Science ®Google Scholar
• Li J, Wu L, Wu W, et al. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Int J Pharm. 2013;455(1–2):75–84. doi:10.1016/j.ijpharm.2013.07.057
   PubMed Web of Science ®Google Scholar
• Hathout RM. Particulate systems in the enhancement of the antiglaucomatous drug pharmacodynamics: a meta-analysis study. ACS omega. 2019;4(26):21909–21913. doi:10.1021/acsomega.9b02895
   PubMed Web of Science ®Google Scholar
• ElMasry SR, Hathout RM, Abdel-Halim M, Mansour M. In vitro transdermal delivery of sesamol using oleic acid chemically-modified gelatin nanoparticles as a potential breast cancer medication. J Drug Deliv Sci Technol. 2018;48:30–39. doi:10.1016/j.jddst.2018.08.017
   Web of Science ®Google Scholar
• Draize JH. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377–390.
   Web of Science ®Google Scholar
• Ossama M, Hathout RM, Attia DA, Mortada ND. Enhanced Allicin Cytotoxicity on HEPG-2 Cells Using Glycyrrhetinic Acid Surface-Decorated Gelatin Nanoparticles. ACS Omega. 2019;4(6):11293-11300. doi:10.1021/acsomega.9b01580
   Web of Science ®Google Scholar